What you know and trust – soon with a new shine!
Euroimmun is modernizing its brand appearance.
At ADLM 2025 (July 27-31), we will show you our new, modernized look for the first time
We're proud to unveil Euroimmun's new visual identity – clearer, more modern, more international and aligned with our parent company, Revvity, Inc.
With this visual change, we likewise renew our commitment to scientific expertise, high-quality standards and dignostic innovation.
See the new look of Euroimmun at ADLM 2025.
From Autoimmune To Endocrinology, We Help You Drive - Stop By Booth #725 and See EUROIMMUN Come Alive!
Display Date: Wednesday, July 30, 2025 • Presentation Time: 1:30 PM – 2:30 PM
Presenter: Dr. Maite Sabalza
Poster Board # A-322
Poster Title: ELISA-based determination of anti-mumps IgG reveals a prevalence of 80 percent in sera obtained in Brazil
Session Topic: Microbiology and Infectious Disease
Poster Board # B-321
Poster Title: Development and evaluation of i-Tracker Risankizumab and i-Tracker Anti-Risankizumab kits: fast and innovative chemiluminescent assays for the monitoring of patients treated with Risankizumab
Session Topic: Therapeutic Drug Monitoring and Toxicology
Poster Board # B-101
Poster Title: Performance assessment of a newly developed chemiluminescence assay for anti-CCP determination
Session Topic: Clinical and Diagnostic Immunology
Poster Board #A-282
Poster Title: Detection of anti-Oropouche virus-specific IgM in a patient panel from a Zika virus epidemic area in 2015 / 2016
Session Topic: Microbiology and Infectious Disease